Q32 BioQTTB -1.72%17 ROA % is -48.52% as of Mar. 2026. GuruFocus rates QTTB with a GF Score™ of 17/100. The stock has 6 warning signs investors should review. Among 1,413 Biotechnology companies, Q32 Bio ranks better than 98.73% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Q32 Bio's annualizedNet Income for the quarter that ended in Mar. 2026 was $-30.44 Mil.
Q32 Bio's average Total Assets over the quarter that ended in Mar. 2026 was $62.73 Mil. Therefore, Q32 Bio's annualized ROA % for the quarter that ended in Mar. 2026 was -48.52%.
The historical rank and industry rank for Q32 Bio's ROA % or its related term are showing as below:
QTTB'
s ROA % Range Over the Past 10 Years
Min: -106.86 Med: -88.33 Max: 50.61
Current: 50.61
During the past 5 years, Q32 Bio's highest ROA % was 50.61%. The lowest was -106.86%. And the median was -88.33%.
QTTB's ROA % is ranked better than 98.73% of 1413
companies
in the Biotechnology industry
Industry Median: -32.67
vs QTTB: 50.61
Q32 Bio (NAS:QTTB) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Q32 Bio ROA % Related Terms
Q32 Bio ROA % Historical Data
* Premium members only.
The historical data trend for Q32 Bio's ROA % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Q32 Bio's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Q32 Bio ROA % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Q32 Bio's ROA % distribution charts can be found below:
* The bar in red indicates where Q32 Bio's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
Q32 Bio (QTTB) has a ROA % of -48.52% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Q32 Bio and its competitors. According to the industry distribution chart, Q32 Bio ranks #18 out of 1413 companies in the Biotechnology industry, placing it in the top 1.3%.
Is Q32 Bio's ROA % too high?
Q32 Bio's current ROA % is -48.52%. Based on the distribution chart, Q32 Bio ranks #18 out of 1413 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Q32 Bio has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Q32 Bio's ROA % compare to CAMP and CDXS?
According to the Biotechnology industry distribution chart, Q32 Bio ranks #18 out of 1413 companies for ROA %. This places Q32 Bio in the top 1% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Biotechnology company?
A good ROA % depends on the Biotechnology industry context. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Q32 Bio and its competitors. Q32 Bio's current ROA % is -48.52%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Q32 Bio stock overvalued right now?
Q32 Bio (QTTB) has a current ROA % of -48.52%. The current ROA % is -48.52%. Q32 Bio's overall GF Score™ is 17/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Q32 Bio (QTTB), the current ROA % is -48.52% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to restore healthy immune balance in patients with alopecia areata (AA) and other autoimmune and inflammatory diseases driven by immune dysfunction. Its product candidate, bempikibart (ADX 914), is a fully human anti-interleukin 7 receptor alpha (IL-7R) antagonist monoclonal antibody designed to block signaling mediated by interleukin 7 (IL 7) and thymic stromal lymphopoietin (TSLP) and re-regulate adaptive immune function. The company has completed two Phase 2a clinical trials evaluating bempikibart, SIGNAL AA Part A for the treatment of alopecia areata and SIGNAL AD for the treatment of atopic dermatitis (AD).
17GF Score
Get the complete analysis for QTTB
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
QTTB has been successfully added to your 
